How to manage an infected arterial ulcer in a patient with severe kidney compromise and impaired renal function, who is refusing dialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Infected Arterial Ulcer in Severe Kidney Compromise Without Dialysis

In a patient with severe kidney compromise refusing dialysis who has an infected arterial ulcer, prioritize aggressive infection control with renally-adjusted broad-spectrum antibiotics and local wound management, while recognizing this represents a palliative care scenario with high mortality risk where limb salvage may be unachievable. 1, 2, 3

Immediate Infection Control

Antimicrobial Therapy

  • Initiate broad-spectrum antibiotics immediately within 1 hour of recognizing infection, as survival benefit outweighs nephrotoxicity concerns even in severe renal impairment 1, 4
  • Start with vancomycin plus piperacillin-tazobactam as empiric coverage for polymicrobial infection typical of arterial ulcers 1
  • Vancomycin dosing in severe renal impairment (CrCl <30 mL/min): Initial loading dose of 15 mg/kg regardless of renal function, followed by maintenance dosing of 250-1000 mg every several days based on levels; in anuria, 1000 mg every 7-10 days 5
  • Piperacillin-tazobactam dosing in severe renal impairment (CrCl ≤40 mL/min): Reduce dose according to degree of renal impairment; standard dosing carries increased risk of neurotoxicity and seizures 6
  • Obtain blood cultures before antibiotic administration but do not delay antibiotics for culture results 1, 4

Avoid Additional Nephrotoxins

  • Each additional nephrotoxin increases acute kidney injury odds by 53%, and combining 3 or more nephrotoxins doubles AKI risk 7, 4
  • Avoid NSAIDs, aminoglycosides (unless no alternative exists), and contrast agents for imaging 7, 4
  • Adjust all renally-cleared medications for decreased GFR 4

Local Wound Management

Wound Care Without Revascularization

  • Perform daily wound inspection with palpation through dressings to assess for worsening infection 1
  • Use 0.5% chlorhexidine preparation with alcohol for wound cleansing before dressing changes 1
  • Apply maximal sterile barrier precautions during any wound manipulation including cap, mask, sterile gown, sterile gloves 1
  • Remove obviously necrotic tissue only if it can be done without causing bleeding, as hemostasis will be impaired 1

Recognize Futility of Revascularization

  • Patients with severe renal insufficiency refusing dialysis have 1-year mortality of 44% even with aggressive treatment 3
  • Renal disease is a more important predictor of poor outcome after revascularization than commonly expected, with typical limb salvage rates of only 50% even among survivors 2
  • Persistent ischemia, extensive infection, forefoot/heel gangrene, and dialysis-dependent renal failure all adversely affect outcomes 2
  • Contrast-based vascular imaging carries prohibitive risk of further renal deterioration in this population 2

Supportive Care and Symptom Management

Hemodynamic Support if Septic

  • If patient develops septic shock, administer at least 30 mL/kg isotonic crystalloids targeting mean arterial pressure ≥65 mmHg 1, 4
  • Use norepinephrine as first-line vasopressor if needed 1, 4
  • Do not use sodium bicarbonate to improve hemodynamics if pH ≥7.15 1, 7, 4

Glucose Control

  • Target blood glucose ≤180 mg/dL using protocolized insulin therapy; avoid tight control (≤110 mg/dL) 1, 4
  • Monitor glucose every 1-2 hours until stable, then every 4 hours 1

Anemia Management

  • Monitor hemoglobin levels closely as anemia is nearly universal in ESRD patients 8
  • Consider erythropoietin and blood transfusion for severe anemia (hemoglobin <8.5 g/dL) 1
  • Be aware that iron overload from excessive IV iron can occur and should be monitored 8

VTE and Stress Ulcer Prophylaxis

  • Provide pharmacologic VTE prophylaxis with low-molecular-weight heparin unless contraindicated by bleeding risk 1, 4
  • Use proton pump inhibitor or H2-receptor antagonist for stress ulcer prophylaxis given GI bleeding risk factors 1, 4

Palliative Care Framework

Acknowledge Conservative Management Context

  • Conservative kidney management (CKM) is a holistic, proactive treatment for kidney failure that for elderly comorbid patients can improve symptom burden and align with quality-of-life goals 9
  • This patient's refusal of dialysis represents a selection related to life or death that must be respected 10
  • Time between initial counseling and outcome (urgent dialysis or death) averages 115 days in patients refusing dialysis 10

Symptom-Focused Approach

  • Prioritize symptom burden assessment as ESRD patients have high physical symptom burden requiring ongoing palliative care approaches 8
  • A palliative care perspective is appropriate for ESRD patients with severely limited life expectancy, focusing on symptom management rather than definitive surgical intervention 8
  • Nephrologists should remain actively involved through end-of-life care 9

Pain Management

  • Provide adequate analgesia for ulcer pain, adjusting opioid doses for renal impairment
  • Monitor for uremic symptoms including nausea, pruritus, and altered mental status

Monitoring Parameters

  • Serial creatinine and electrolytes every 4-6 hours if septic, otherwise daily 4
  • Vancomycin trough levels to guide dosing adjustments 5
  • Complete blood count to monitor for anemia and thrombocytopenia 1
  • Bleeding time if considering any invasive procedures, as bleeding times >10-15 minutes indicate high hemorrhage risk 1
  • Daily wound assessment for progression of infection or necrosis 1

Critical Prognostic Information

  • Severe renal insufficiency (GFR <30 mL/min) increases odds of death 2.97-fold in patients with critical limb ischemia 3
  • Patients with gangrene or ischemic ulceration have 87% prevalence in severe renal insufficiency versus 70% in normal renal function 3
  • High 1-year mortality of 38-44% must be considered when discussing treatment goals 2, 3
  • Without dialysis, progressive uremia will develop with severe symptoms typically within 3-4 months 10

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Septic Shock in Renal Transplant Recipients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tocilizumab in Sepsis-Induced Acute Kidney Injury

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Heavy Menstrual Bleeding in ESRD Patients on Dialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Refusal of initiation of dialysis by elderly patients with chronic renal failure].

Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2005

Related Questions

What is the best management approach for a 70-year-old patient with type 2 diabetes, active right foot osteomyelitis, severe peripheral arterial disease (PAD), and mixed arterial and venous insufficiency?
What can be done for a patient with End-Stage Renal Disease (ESRD), anuria, and impaired renal function, when dialysis is not available?
Should I apply a tensor to a patient with a graft wound on the bottom of their foot, likely with a history of diabetes or peripheral arterial disease, without an available Ankle-Brachial Pressure Index (ABPI) measurement?
At what creatinine level do you consider a patient to have severe renal insufficiency?
What is the role of acetazolamide in a diuresis strategy, particularly in patients with conditions like heart failure or nephrotic syndrome?
What is the recommended treatment approach for a patient with severe nodular or conglobate acne, particularly those who have not responded to oral antibiotics or topical retinoids?
What is an alternative or augmentation to sertraline (Selective Serotonin Reuptake Inhibitor) for a patient with Obsessive-Compulsive Disorder (OCD), Social Anxiety Disorder (SAD), and Generalized Anxiety Disorder (GAD), who is experiencing significant sexual dysfunction, emotional blunting, and fatigue?
When is blood transfusion considered for pediatric patients with tetralogy of Fallot?
What causes premature atrial contractions (PACs) on an electrocardiogram (ECG)?
Can a vitamin B12 level of 385 pg/mL and a folate level of 5.5 ng/mL cause tingling sensations in a patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.